L’Oréal skin care technology
This article was originally published in The Rose Sheet
Executive Summary
L'Oréal jointly developing SkinChip sensor technology with Geneva-based STMicroelectronics as research tool to "quickly and easily" provide detailed hydration analysis of human skin, firm announces Oct. 18. SkinChip will mark first use of semiconductors in development of "next-generation" skin care products, company adds. Technology, based on ST's existing TouchChip biometric fingerprint recognition applications, will allow L'Oréal to develop skin care products to address age-related changes in the skin...
You may also be interested in...
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.
GLP-1 Coverage Restrictions In Medicare Part D Surge As Demand For Obesity Drugs Grows
A major shift from unfettered coverage to prior authorizations was recorded by MMIT over the past year for the leading GLP-1/GIP agonist diabetes drugs. Public interest in using the drugs off label for weight loss drove the change.